Abstract
Background: Data from the WHO show an increasing rate of overweight and obesity in general population in the last decades. This increase in obesity also affects population with end-stage renal disease (ESRD) and kidney transplant (KT) candidates. Summary: In this review, we focused on how obesity impacts on KT stages: access to KT and outcomes of KT candidates; how to reduce weight and its consequences; short and long-term outcomes in obese recipients and the impact of weight variations; and the implications of obesity in living donor KT. We searched MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials until November 30, 2020. We selected systematic reviews and meta-analyses and randomized clinical trials. When no such reports were found for a topic, observational studies were included in the assessment. Key Messages: Although obesity is a risk factor to present worst outcomes after KT, several studies have demonstrated a survival benefit compared to patients who continue on dialysis. There is a need for a public health campaign to raise awareness in KT candidates and to highlight the importance of self-care, increasing exercise, healthy diet, and weight loss.
References
1.
World Health Organization
. Obesity and overweight [Internet]. 2018
.2.
Hoogeveen
EK
. Re: effect of obesity on the outcome of kidney transplantation: a 20-year follow-up
. Transplantation
. 2011
;91
(8
):869
–74
.3.
Kramer
HJ
, Saranathan
A
, Luke
A
, Durazo-Arvizu
RA
, Guichan
C
, Hou
S
, Increasing body mass index and obesity in the incident ESRD population
. J Am Soc Nephrol
. 2006
;17
(5
):1453
–9
. .4.
Neale
J
, Smith
AC
. Cardiovascular risk factors following renal transplant
. World J Transplant
. 2015
;5
(4
):183
. .5.
Zoccali
C
, Torino
C
, Tripepi
G
, Tripepiand
G
, Mallamaci
F
. Assessment of obesity in chronic kidney disease: what is the best measure?
Curr Opin Nephrol Hypertens
. 2012
;21
(6
):641
–6
. .6.
Okorodudu
DO
, Jumean
MF
, Montori
VM
, Romero-Corral
A
, Somers
VK
, Erwin
PJ
, Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis
. Int J Obes
. 2010
;34
(5
):791
–9
. .7.
Perreault
L
. Obesity in adults: Prevalence, screening, and evaluation - UpToDate [Internet]. 2020
.8.
Marra
M
, Sammarco
R
, De Lorenzo
A
, Iellamo
F
, Siervo
M
, Pietrobelli
A
, Assessment of body composition in health and disease using bioelectrical impedance analysis (bia) and dual energy x-ray absorptiometry (dxa): a critical overview
. Contrast Media Mol Imaging
. 2019
;2019
:1
. .9.
Von Düring
ME
, Jenssen
T
, Bollerslev
J
, Åsberg
A
, Godang
K
, Eide
IA
, Visceral fat is better related to impaired glucose metabolism than body mass index after kidney transplantation
. Transpl Int
. 2015
;28
(10
):1162
–71
.10.
Kalantar-Zadeh
K
, Kopple
JD
, Kilpatrick
RD
, McAllister
CJ
, Shinaberger
CS
, Gjertson
DW
, Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population
. Am J Kidney Dis
. 2005
;46
(3
):489
–500
. .11.
Gill
JS
, Lan
J
, Dong
J
, Rose
C
, Hendren
E
, Johnston
O
, The survival benefit of kidney transplantation in obese patients
. Am J Transplant
. 2013
;13
(8
):2083
–90
. .12.
Dudley
C
, Harden
P
. Renal association clinical practice guideline on the assessment of the potential kidney transplant recipient
. Nephron Clin Pract
. 2011
;118
(Suppl 1
):c209
–24
. .13.
Abramowicz
D
, Cochat
P
, Claas
FH
, Heemann
U
, Pascual
J
, Dudley
C
, European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care
. Nephrol Dial Transplant
. 2015
;30
(11
):1790
–7
. .14.
KDIGO
. KDIGO–Evaluation and management of candidates for KTX–draft–not final! Development. 2018 Oct
.15.
Campbell
S
, Pilmore
H
, Gracey
D
, Mulley
W
, Russell
C
, McTaggart
S
. KHA-cari guideline: recipient assessment for transplantation
. Nephrology
. 2013
;18
(6
):455
–62
. .16.
Stenvinkel
P
, Ikizler
TA
, Mallamaci
F
, Zoccali
C
. Obesity and nephrology: results of a knowledge and practice pattern survey
. Nephrol Dial Transplant
. 2013
;28
(Suppl 4
):iv99
–104
. .17.
Pondrom
S
. How big is too big?
Am J Transplant
. 2012
;12
:1663
–4
.18.
Gill
JS
, Hendren
E
, Dong
J
, Johnston
O
, Gill
J
. Differential association of body mass index with access to kidney transplantation in men and women
. Clin J Am Soc Nephrol
. 2014
;9
(5
):951
–9
. .19.
Segev
DL
, Simpkins
CE
, Thompson
RE
, Locke
JE
, Warren
DS
, Montgomery
RA
. Obesity impacts access to kidney transplantation
. J Am Soc Nephrol
. 2008
;19
(2
):349
–55
. .20.
Hannedouche
T
, Lassalle
M
, Massy
A
. Obesity and access to kidney transplantation in patients starting dialysis: a prospective cohort study
. PLoS One
. 2017
;12
:e0176616
.21.
Harhay
MN
, Ranganna
K
, Boyle
SM
, Brown
AM
, Bajakian
T
, Levin Mizrahi
LB
, Association between weight loss before deceased donor kidney transplantation and posttransplantation outcomes
. Am J Kidney Dis
. 2019
;74
(3
):361
–72
. .22.
Molnar
MZ
, Streja
E
, Kovesdy
CP
, Bunnapradist
S
, Sampaio
MS
, Jing
J
, Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients
. Am J Transplant
. 2011
;11
(4
):725
–36
. .23.
Huang
E
, Bunnapradist
S
. Pre-transplant weight loss and survival after kidney transplantation
. Am J Nephrol
. 2015
;41
(6
):448
–55
. .24.
Coutinho
AK
, Glancey
GR
. Orlistat, an under-recognised cause of progressive renal impairment
. Nephrol Dial Transplant
. 2013
;28
(Suppl 4
):iv172
–4
. .25.
Scirica
BM
, Bohula
EA
, Dwyer
JP
, Qamar
A
, Inzucchi
SE
, McGuire
DK
, Lorcaserin and renal outcomes in obese and overweight patients in the CAMELLIA-TIMI 61 trial
. Circulation
. 2019
;139
(3
):366
–75
. .26.
Pi-Sunyer
X
, Astrup
A
, Fujioka
K
, Greenway
F
, Halpern
A
, Krempf
M
, A randomized, controlled trial of 3.0 mg of liraglutide in weight management
. N Engl J Med
. 2015
;373
(1
):11
–22
. .27.
Coates
PT
, Devuyst
O
, Wong
G
, Okusa
M
, Oliver
J
, York
N
, International. KDIGO guidel 2020 diabetes CKD
. 2020
;98
(4
).28.
Idorn
T
, Knop
FK
, Jørgensen
MB
, Jensen
T
, Resuli
M
, Hansen
PM
, Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: an investigator-initiated, placebo-controlled, double-blind, parallel-group, randomized trial
. Diabetes Care
. 2016
;39
(2
):206
–13
. .29.
Lesage
J
, Gill
JS
. Management of the obese kidney transplant candidate
. Transplant Rev
. 2017
;31
(1
):35
–41
. .30.
Andalib
A
, Aminian
A
, Khorgami
Z
, Navaneethan
SD
, Schauer
PR
, Brethauer
SA
. Safety analysis of primary bariatric surgery in patients on chronic dialysis
. Surg Endosc
. 2016
;30
(6
):2583
–91
. .31.
Gaillard
M
, Tranchart
H
, Beaudreuil
S
, Lebrun
A
, Voican
CS
, Lainas
P
, Laparoscopic sleeve gastrectomy for morbid obesity in renal transplantation candidates: a matched case–control study
. Transpl Int
. 2020
;33
(9
):1061
–70
.32.
Dobrzycka
M
, Proczko-Stepaniak
M
, Kaska
Ł
, Wilczyński
M
, Dębska-Ślizień
A
, Kobiela
J
. Weight loss after bariatric surgery in morbidly obese end-stage kidney disease patients as preparation for kidney transplantation. matched pair analysis in a high-volume bariatric and transplant center
. Obes Surg
. 2020
;30
(7
):2708
–14
. .33.
Yemini
R
, Nesher
E
, Carmeli
I
, Winkler
J
, Rahamimov
R
, Mor
E
, Bariatric surgery is efficacious and improves access to transplantation for morbidly obese renal transplant candidates
. Obes Surg
. 2019
;29
(8
):2373
–80
.34.
Bouchard
P
, Tchervenkov
J
, Demyttenaere
S
, Court
O
, Andalib
A
. Safety and efficacy of the sleeve gastrectomy as a strategy towards kidney transplantation
. Surg Endosc
. 2020
;34
(6
):2657
–64
. .35.
Yemini
R
, Nesher
E
, Winkler
J
, Carmeli
I
, Azran
C
, Ben David
M
, Bariatric surgery in solid organ transplant patients: long-term follow-up results of outcome, safety, and effect on immunosuppression
. Am J Transplant
. 2018
;18
(11
):2772
–80
. .36.
Nicoletto
BB
, Fonseca
NK
, Manfro
RC
, Gonçalves
LF
, Leitão
CB
, Souza
GC
. Effects of obesity on kidney transplantation outcomes: a systematic review and meta-analysis
. Transplantation
. 2014
;98
(2
):167
–76
. .37.
Lafranca
JA
, IJermans
JN
, Betjes
MG
, Dor
FJ
. Body mass index and outcome in renal transplant recipients: a systematic review and meta-analysis
. BMC Med
. 2015
;13
(1
):111
. .38.
Hill
CJ
, Courtney
AE
, Cardwell
CR
, Maxwell
AP
, Lucarelli
G
, Veroux
M
, Recipient obesity and outcomes after kidney transplantation: a systematic review and meta-analysis
. Nephrol Dial Transplant
. 2015
;30
(8
):1403
–11
. .39.
Liese
J
, Bottner
N
, Büttner
S
, Reinisch
A
, Woeste
G
, Wortmann
M
, Influence of the recipient body mass index on the outcomes after kidney transplantation
. Langenbecks Arch Surg
. 2018
;403
(1
):73
–82
. .40.
Erturk
T
, Berber
I
, Cakir
U
. Effect of obesity on clinical outcomes of kidney transplant patients
. Transplant Proc
. 2019
;51
(4
):1093
–5
. .41.
Montero
N
, Quero
M
, Arcos
E
, Comas
J
, Rama
I
, Lloberas
N
, Effects of body weight variation in obese kidney recipients: a retrospective cohort study
. Clin Kidney J
. 2019
;1–9
.42.
Aziz
F
, Ramadorai
A
, Parajuli
S
, Garg
N
, Mohamed
M
, Mandelbrot
DA
, Obesity: an independent predictor of morbidity and graft loss after kidney transplantation
. Am J Nephrol
. 2020
;51
(8
):615
–23
. .43.
Fellmann
M
, Balssa
L
, Clément
E
, Frey
P
, Frontczak
A
, Bernardini
S
, Effects of obesity on postoperative complications and graft survival after kidney transplantation
. Transplant Proc Elsevier Inc
. 2020
;7
:1
–7
.44.
Ahmadi
S-F
, Zahmatkesh
G
, Streja
E
, Molnar
MZ
, Rhee
CM
, Kovesdy
CP
, Body mass index and mortality in kidney transplant recipients: a systematic review and meta-analysis
. Am J Nephrol
. 2014
;40
(4
):315
–24
.45.
Flabouris
K
, Chadban
S
, Ladhani
M
, Cervelli
M
, Clayton
P
. Body mass index, weight-adjusted immunosuppression and the risk of acute rejection and infection after kidney transplantation: a cohort study
. Nephrol Dial Transplant
. 2019
;34
(12
):2132
–43
. .46.
Mehta
A
, Ghazanfar
A
, Marriott
A
, Morsy
M
. Where to draw the line in surgical obesity for renal transplant recipients: an outcome analysis based on body mass index
. Exp Clin Transplant
. 2019
;17
(1
):37
–41
. .47.
Ducloux
D
, Kazory
A
, Simula-Faivre
D
, Chalopin
JM
. One-year post-transplant weight gain is a risk factor for graft loss
. Am J Transplant
. 2005
;5
(12
):2922
–8
. .48.
Khwaja
A
, El-Nahas
M
. Transplantation in the obese: separating myth from reality
. Nephrol Dial Transplant
. 2012
;27
(10
):3732
–5
. .49.
Kurnatowska
I
, Małyska
A
, Wysocka
K
, Mazur
K
, Krawczyk
J
, Nowicki
M
. Long-term effect of body mass index changes on graft damage markers in patients after kidney transplantation
. Ann Transplant
. 2016
;21
:626
–31
. .50.
Hassanain
M
, Simoneau
E
, Doi
SA
, Aljiffry
M
, Aloraini
A
, Madkhali
A
, Trends in brain-dead organ donor characteristics: a 13-year analysis
. Can J Surg
. 2016
;59
(3
):154
–60
. .51.
Gore
JL
, Pham
PT
, Danovitch
GM
, Wilkinson
AH
, Rosenthal
JT
, Rosenthal
JT
, Obesity and outcome following renal transplantation
. Am J Transplant
. 2006
;6
(2
):357
–63
. .52.
Ortiz
J
, Gregg
A
, Wen
X
, Karipineni
F
, Kayler
LK
. Impact of donor obesity and donation after cardiac death on outcomes after kidney transplantation
. Clin Transplant
. 2012
;26
(3
):E284
–92
. .53.
Miller
AJ
, Kiberd
BA
, Alwayn
IP
, Odutayo
A
, Tennankore
KK
. Donor-recipient weight and sex mismatch and the risk of graft loss in renal transplantation
. Clin J Am Soc Nephrol
. 2017
;12
(4
):669
–76
. .54.
Heimbach
JK
, Taler
SJ
, Prieto
M
, Cosio
FG
, Textor
SC
, Kudva
YC
, Obesity in living kidney donors: clinical characteristics and outcomes in the era of laparoscopic donor nephrectomy
. Am J Transplant
. 2005
;5
(5
):1057
–64
. .55.
Serrano
OK
, Sengupta
B
, Bangdiwala
A
, Vock
DM
, Dunn
TB
, Finger
EB
, Implications of excess weight on kidney donation: long-term consequences of donor nephrectomy in obese donors
. Surgery
. 2018
;164
(5
):1071
–6
. .56.
Taler
SJ
, Messersmith
EE
, Leichtman
AB
, Gillespie
BW
, Kew
CE
, Stegall
MD
, Demographic, metabolic, and blood pressure characteristics of living kidney donors spanning five decades
. Am J Transplant
. 2013
;13
(2
):390
–8
. .57.
Locke
JE
, Reed
RD
, Massie
A
, MacLennan
PA
, Sawinski
D
, Kumar
V
, Obesity increases the risk of end-stage renal disease among living kidney donors
. Kidney Int
. 2017
;91
(3
):699
–703
. .58.
Praga
M
, Hernández
E
, Herrero
JC
, Morales
E
, Revilla
Y
, Díaz-González
R
, Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy
. Kidney Int
. 2000
;58
(5
):2111
–8
. .59.
Rea
DJ
, Heimbach
JK
, Grande
JP
, Textor
SC
, Taler
SJ
, Prieto
M
, Glomerular volume and renal histology in obese and non-obese living kidney donors
. Kidney Int
. 2006
;70
(9
):1636
–41
. .60.
Metha
A
, Ghazanfar
A
, Marriott
A
, Morsy
M
. Where to Draw the Line in Surgical Obesity for Renal Transplant Recipients: An Outcome Analysis Based on Body Mass Index
. Exp Cli Transplant
. 2019 Feb
;17
(1
):37
–41
. .61.
Wu DA, Robb ML, Forsythe JLR, Bradley C, Cairns J, Draper H, et al. Recipient Comorbidity and Survival Outcomes after Kidney Transplantation: A UK-Wide Prospective Cohort Study. Transplantation. 2020 Jun;104(6):1246–55.
62.
Bellini
MI
, Koutroutsos
K
, Nananpragasam
H
, Deurloo
E
, Galliford
J
, Herbert
PE
. Obesity affects graft function but not graft loss in kidney transplant recipients
. J Int Med Res
. 2020 Jan
;48
(1
):0300060519895139
. .© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
